These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 863531

  • 1. Sumpeak calibration of 123I.
    Brinkman GA, Lindner L, Veenboer JT.
    Int J Appl Radiat Isot; 1977 Mar; 28(3):271-5. PubMed ID: 863531
    [No Abstract] [Full Text] [Related]

  • 2. Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.
    Shulkin BL, Shapiro B, Tobes MC, Shen SW, Wieland DM, Meyers LJ, Lee HT, Petry NA, Sisson JC, Beierwaltes WH.
    J Nucl Med; 1986 Jul; 27(7):1138-42. PubMed ID: 3723189
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Absorbed radiation dose from radionuclidic impurities in several 123I-labeled radiopharmaceuticals.
    Colombetti LG, Barnes WE.
    Nuklearmedizin; 1976 Jun; 15(3):152-5. PubMed ID: 958903
    [Abstract] [Full Text] [Related]

  • 6. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [Abstract] [Full Text] [Related]

  • 7. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
    Kersemans V, Cornelissen B, Bacher K, Kersemans K, Thierens H, Dierckx RA, De Spiegeleer B, Slegers G, Mertens J.
    J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
    [Abstract] [Full Text] [Related]

  • 8. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.
    Leslie WD, Abrams DN, Greenberg CR, Hobson D.
    J Nucl Med; 1996 Oct; 37(10):1589-91. PubMed ID: 8862288
    [Abstract] [Full Text] [Related]

  • 9. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
    Bomanji J, Mather S, Moyes J, Ellison D, Grossman A, Britton KE, Besser GM.
    J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
    [Abstract] [Full Text] [Related]

  • 10. Comparative dosimetry of 124Te(p, 2n)123I and 124Xe(p, 2m)123I.
    Maguire WJ.
    Health Phys; 1989 Jul; 57(1):195-7. PubMed ID: 2745083
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
    de Herder WW, Reijs AE, de Swart J, Kaandorp Y, Lamberts SW, Krenning EP, Kwekkeboom DJ.
    Eur J Nucl Med; 1999 Jan; 26(1):46-50. PubMed ID: 9933661
    [Abstract] [Full Text] [Related]

  • 12. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography.
    Almeida P, Ribeiro MJ, Bottlaender M, Loc'h C, Langer O, Strul D, Hugonnard P, Grangeat P, Mazière B, Bendriem B.
    Eur J Nucl Med; 1999 Dec; 26(12):1580-8. PubMed ID: 10638410
    [Abstract] [Full Text] [Related]

  • 13. Focal accumulation of iodine-123-BMIPP in liposarcoma of the thigh.
    Suto Y, Tanabe Y, Ohta Y.
    J Nucl Med; 1996 Jun; 37(6):997-9. PubMed ID: 8683332
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [123I or 131I nephrography in iodine allergy, thyroid autonomy or hyperthyroidism].
    Wolf F, Becker W.
    Dtsch Med Wochenschr; 1990 Aug 31; 115(35):1333. PubMed ID: 2390950
    [No Abstract] [Full Text] [Related]

  • 17. Significance of radiocontaminants in 123I for dosimetry and scintillation camera imaging.
    Baker GA, Lum DJ, Smith EM, Winchell HS.
    J Nucl Med; 1976 Aug 31; 17(8):740-3. PubMed ID: 932820
    [Abstract] [Full Text] [Related]

  • 18. A novel 123I-labeling reagent. XIII. Synthesis and loading-dose effects of 123I-iodophenylalanine and 123I-5- and6-iodotryptophan.
    Lambrecht RM, Atkins H, Elias H, Fowler JS, Lin SS, Wolf AP.
    J Nucl Med; 1974 Oct 31; 15(10):863-7. PubMed ID: 4425320
    [No Abstract] [Full Text] [Related]

  • 19. Radiolabeling of paclitaxel with electrophilic 123I.
    Roh EJ, Park YH, Song CE, Oh SJ, Choe YS, Kim BT, Chi DY, Kim D.
    Bioorg Med Chem; 2000 Jan 31; 8(1):65-8. PubMed ID: 10968265
    [Abstract] [Full Text] [Related]

  • 20. [Clinical uses of I-123 produced by 127I(p, 5n) 123Xe to 123I reaction in NIRS (author's transl)].
    Saegusa K, Arimizu N, Uchiyama G, Tateno Y, Rikitake T, Suzuki K, Ido T.
    Kaku Igaku; 1978 Aug 31; 15(5):751-4. PubMed ID: 722988
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.